Tamm M, Reichenberger F, McGandy C E, Stalder A, Tietz A, Dalquen P, Perruchoud A P, Cathomas G
Department of Internal Medicine and Institute of Pathology, University Hospital Basel, Switzerland.
Am J Respir Crit Care Med. 1998 Feb;157(2):458-63. doi: 10.1164/ajrccm.157.2.9707068.
Human herpes virus 8 (HHV8) DNA has recently been detected in sarcoma tissue of patients with Kaposi's sarcoma. HHV8 DNA could also be found in bronchoalveolar lavage (BAL) fluid of patients with tracheobronchial Kaposi's sarcoma. To determine the specificity, sensitivity and predictive values of HHV8 DNA detection in the BAL for the diagnosis of pulmonary Kaposi's sarcoma, 100 consecutive BAL were prospectively analyzed for the presence of HHV8 DNA using a nested PCR assay. In addition, 19 BAL samples of 14 AIDS patients with cutaneous or visceral Kaposi's sarcoma were retrospectively investigated. The prospective group consisted of 79 BAL performed in immunocompromised and of 21 BAL in nonimmunocompromised patients. Four patients of the prospectively analyzed group undergoing six BAL showed tracheobronchial Kaposi's sarcoma at five bronchoscopies. All of the five BAL samples performed in these patients with endoscopically visible Kaposi's sarcoma were positive for HHV8 DNA. Following chemotherapy and antiretroviral treatment tracheobronchial Kaposi's sarcoma was no longer detectable at a subsequent bronchoscopy and HHV8 DNA in BAL became negative in one patient. One BAL sample of a HIV-positive patient with no evidence of Kaposi's sarcoma was HHV8 DNA-positive. The sensitivity, specificity, positive and negative predictive values of HHV8 detection for the diagnosis of tracheobronchial Kaposi's sarcoma were 100%, 98.9%, 83.3%, and 100%, respectively. Twelve of 19 BAL samples of the retrospective group were HHV8 DNA-positive. In this group, 10 patients undergoing a total of 14 BAL suffered from pulmonary Kaposi's sarcoma. HHV8 DNA was documented in 10 of these 14 BAL samples. In three BAL of this group HHV8 DNA was positive, but pulmonary Kaposi's sarcoma was diagnosed at a later stage. In conclusion, the detection of HHV8 DNA in BAL is restricted to patients with Kaposi's sarcoma and is highly sensitive and specific for pulmonary involvement of Kaposi's sarcoma.
最近在卡波西肉瘤患者的肉瘤组织中检测到了人疱疹病毒8(HHV8)DNA。在气管支气管卡波西肉瘤患者的支气管肺泡灌洗(BAL)液中也能发现HHV8 DNA。为了确定BAL中HHV8 DNA检测对肺卡波西肉瘤诊断的特异性、敏感性和预测价值,使用巢式聚合酶链反应(PCR)分析方法对连续100例BAL样本进行前瞻性分析,以检测HHV8 DNA的存在。此外,对14例患有皮肤或内脏卡波西肉瘤的艾滋病患者的19份BAL样本进行了回顾性研究。前瞻性研究组包括79例免疫功能低下患者的BAL样本和21例非免疫功能低下患者的BAL样本。前瞻性分析组中4例接受6次BAL检查的患者在5次支气管镜检查时显示有气管支气管卡波西肉瘤。在这些内镜可见卡波西肉瘤的患者所进行的5份BAL样本中,所有样本的HHV8 DNA均呈阳性。化疗和抗逆转录病毒治疗后,在随后的支气管镜检查中未再检测到气管支气管卡波西肉瘤,并且1例患者BAL中的HHV8 DNA变为阴性。1例无卡波西肉瘤证据的HIV阳性患者的1份BAL样本HHV8 DNA呈阳性。HHV8检测对气管支气管卡波西肉瘤诊断的敏感性、特异性、阳性预测值和阴性预测值分别为100%、98.9%、83.3%和100%。回顾性研究组的19份BAL样本中有12份HHV8 DNA呈阳性。在该组中,10例患者共接受了14次BAL检查,患有肺卡波西肉瘤。在这14份BAL样本中的10份中记录到了HHV8 DNA。在该组的3份BAL样本中HHV8 DNA呈阳性,但肺卡波西肉瘤在后期才被诊断出来。总之,BAL中HHV8 DNA的检测仅限于卡波西肉瘤患者,并且对卡波西肉瘤的肺部受累具有高度敏感性和特异性。